[Federal Register Volume 84, Number 58 (Tuesday, March 26, 2019)]
[Notices]
[Pages 11313-11314]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-05716]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Advisory Committee on Blood and Tissue Safety and 
Availability; Amendment

AGENCY: Department of Health and Human Services, Office of the 
Secretary, Office of the Assistant Secretary for Health.

ACTION: Notice; amendment.

-----------------------------------------------------------------------

SUMMARY: A notice was published in the Federal Register on Monday, 
March 11, 2019 (Vol. 84, No. 47, pages 8731-8732),

[[Page 11314]]

to give notice that the Advisory Committee on Blood and Tissue Safety 
and Availability (ACBTSA) will hold a meeting on April 15-16, 2019. The 
notice is being amended to include a registration link for any 
individuals who wish to attend the meeting in-person, as well as a link 
to the ACBTSA website for more information.

DATES: The meeting will take place Monday April 15, 2019, from 8 a.m.-
4:30 p.m. and Tuesday April 16, 2019, from 8:30 a.m.-4 p.m.

ADDRESSES: U.S. Department of Health & Human Services, Hubert H. 
Humphrey Building, (Conference Room 800), 200 Independence Ave. SW, 
Washington, DC 20201. Members of the public may also attend the meeting 
via webcast. Instructions for attending this virtual meeting will be 
posted prior to the meeting at: https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/index.html.

FOR FURTHER INFORMATION CONTACT: Mr. James Berger, Designated Federal 
Officer for the ACBTSA, Senior Advisor for Blood and Tissue Policy, 
Office of the Assistant Secretary for Health, Department of Health and 
Human Services, Mary E. Switzer Building, 330 C Street SW, Suite L100, 
Washington, DC 20024. Phone: (202) 795-7697; Fax: (202) 691-2102; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: In-person attendance at the meetings is 
limited by security restrictions and the space available; therefore 
preregistration for public members is required and can be accomplished 
by registering at https://www.eventbrite.com/e/50th-meeting-of-the-hhs-advisory-committee-on-blood-tissue-safety-availability-tickets-55285257694 by Monday, April 8, 2019. Members of the public may also 
attend the meeting via webcast. Instructions for attending this virtual 
meeting will be posted prior to the meeting at: https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/index.html. Non-U.S. 
citizens who plan to attend in person are required to provide 
additional information and must notify the Working Group support staff 
via email at [email protected] before March 15, 2019. Members of 
the public who wish to attend the meetings should enter from 
Independence Avenue. Please allow extra time to get through security.

    Dated: March 13, 2019.
James J. Berger,
Senior Advisor for Blood and Tissue Policy.
[FR Doc. 2019-05716 Filed 3-25-19; 8:45 am]
 BILLING CODE 4150-28-P